Improving transitions of care for hospitalized patients with opioid use disorder
改善阿片类药物使用障碍住院患者的护理过渡
基本信息
- 批准号:10634761
- 负责人:
- 金额:$ 19.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAmbulatory CareAreaCaringChronicClient satisfactionCommunitiesEvidence based treatmentFutureGoalsGrantHealth Care CostsHealth Services ResearchHealth systemHospitalizationHospitalsIndividualLeadLifeLinkLiteratureManuscriptsMapsMentored Patient-Oriented Research Career Development AwardMentored Research Scientist Development AwardMentorshipMethodsMorbidity - disease rateNational Institute of Drug AbuseOutcomeOutcome MeasurePatient CarePatient DischargePatientsPersonsPharmaceutical PreparationsProviderPublic HealthRainRandomized, Controlled TrialsResearchResearch ActivityResearch PersonnelServicesSystemTestingTrainingTraining ActivityTreatment outcomeVisitWritingacute carecare deliverycommunity settingdesignevidence baseexperienceimplementation scienceimplementation strategyimprovedimproved outcomeintervention deliverymedication for opioid use disordermortalityopioid use disorderpatient engagementpilot testpilot trialprimary outcomesecondary outcomeskillssubstance use
项目摘要
PROJECT SUMMARY/ABSTRACT: The goal of this K23 Mentored Patient-Oriented Research Career
Development Award is to support the applicant in developing the critical skills necessary to become an expert in
increasing access to evidence-based treatment for opioid use disorder (OUD) at touchpoints for care that
individuals with OUD are likely to frequent. The proposed research focuses on NIDA's priority area of addressing
real-world complexities by developing implementation strategies to improve treatment continuity after
hospitalization in patients with OUD. Hospitalizations related to OUD and its complications have increased
dramatically over the last few decades, leading to high morbidity, mortality, and healthcare costs. Hospitals are
increasingly recognized as critical touchpoints for engaging individuals with OUD in treatment, and randomized
controlled trials support the efficacy of initiating medications for OUD (MOUD) in acute care settings to increase
treatment engagement following discharge. However, hospital-initiated treatment is insufficient if patients do not
continue care in the community. Despite the robust literature on care transitions after hospital discharge for
patients with other chronic conditions, there is limited evidence about the best strategies to optimize care
engagement for patients with OUD after hospitalization. We need effective, scalable strategies for linking patients
with OUD from acute care to ongoing treatment, including continuation of MOUDs. The research objective of this
proposal is to develop and pilot test strategies to facilitate transitions of care for patients with OUD from the
hospital to the community. The specific aims are: (1) Use a mixed-methods approach to identify determinants of
effective care transitions for patients with OUD from acute care to outpatient treatment at the patient, provider,
and system level, (2) Partner with hospital and community stakeholders and use implementation mapping to
develop a multicomponent, modular toolkit to facilitate transitions from acute care to community addressing multi-
level barriers, and (3) Conduct a pilot trial of the care transition toolkit. The primary outcome will be treatment
engagement at 30 days, and secondary outcomes will include MOUD and substance use, service use, feasibility,
acceptability and patient satisfaction. The mentorship team brings together experts in health services research,
implementation science, and care delivery interventions for OUD as well as stakeholder advisors from hospital
and community settings. This Mentored Research Scientist Development Award builds on Dr. Lowenstein's
experience as a clinician and researcher and extends it with five key training goals: 1) Measuring outcomes for
OUD-related care across systems, 2) Advanced qualitative inquiry, 3) Implementing health systems change, and
5) Manuscript and grant writing. With successful completion of this project, training activities, and mentorship
from a team of experienced investigators, Dr. Lowenstein will be well-prepared to lead an independent research
agenda designed to improve care and outcomes for people with OUD.
项目总结/摘要:K23指导的以患者为导向的研究生涯的目标
发展奖旨在支持申请人发展成为以下领域专家所需的关键技能:
在接触点增加对阿片类药物使用障碍的循证治疗,
患有OUD的人可能会经常出现。拟议的研究重点是NIDA的优先解决领域
通过制定实施策略来改善治疗的连续性,
OUD患者的住院治疗。与OUD及其并发症相关的住院治疗有所增加
在过去的几十年中,这种疾病急剧增加,导致高发病率、死亡率和医疗保健成本。医院
越来越多地被认为是让OUD患者参与治疗的关键接触点,
对照试验支持在急性护理环境中启动OUD(MOUD)药物治疗的有效性,
出院后进行治疗。然而,如果患者不愿意,
继续在社区中照顾。尽管有大量关于出院后护理过渡的文献,
对于其他慢性病患者,关于优化护理的最佳策略的证据有限
为住院后的OUD患者提供服务。我们需要有效的、可扩展的策略,
从急性护理到持续治疗,包括继续MOUD。本研究的目的是
建议是制定和试点测试策略,以促进从OUD患者的护理过渡到
医院到社区具体目标是:(1)使用混合方法确定
OUD患者从急性护理到门诊治疗的有效护理过渡,
(2)与医院和社区利益相关者合作,并使用实施映射,
开发一个多组件的模块化工具包,以促进从急性护理到社区的过渡,
(3)开展护理过渡工具包的试点试验。主要结果将是治疗
参与30天,次要结果将包括MOUD和物质使用,服务使用,可行性,
可接受性和患者满意度。导师团队汇集了卫生服务研究方面的专家,
实施科学和OUD的护理提供干预以及医院的利益相关者顾问
和社区设置。这个指导研究科学家发展奖建立在博士。
作为临床医生和研究人员的经验,并将其扩展为五个关键培训目标:1)测量结果,
跨系统的OUD相关护理,2)高级定性调查,3)实施卫生系统变革,以及
5)授权书和授权书。成功完成本项目、培训活动和指导
从一个经验丰富的研究团队,洛温斯坦博士将做好充分准备,领导一个独立的研究,
旨在改善OUD患者的护理和结果的议程。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
National Survey in Medical and Surgical Decision-Making for Recurrent Injection Drug Use-Related Infective Endocarditis.
反复注射吸毒相关感染性心内膜炎的医疗和外科决策全国调查。
- DOI:10.1016/j.jaclp.2022.08.008
- 发表时间:2023
- 期刊:
- 影响因子:2.3
- 作者:Zwiebel,Samantha;Meisner,Jessica;Lowenstein,Margaret
- 通讯作者:Lowenstein,Margaret
"Come try it out. Get your foot in the door:" Exploring patient perspectives on low-barrier treatment for opioid use disorder.
“来试试吧。迈出第一步:”探索患者对阿片类药物使用障碍低门槛治疗的看法。
- DOI:10.1016/j.drugalcdep.2023.109915
- 发表时间:2023
- 期刊:
- 影响因子:4.2
- 作者:Lowenstein,Margaret;Abrams,MatthewP;Crowe,Molly;Shimamoto,Kelsey;Mazzella,Silvana;Botcheos,Denise;Bertocchi,Jennifer;Westfahl,Shawn;Chertok,Judy;Garcia,KristinePamela;Truchil,Rachael;Holliday-Davis,M;Aronowitz,Shoshana
- 通讯作者:Aronowitz,Shoshana
Trends in Before Medically Advised Discharges for Patients With Opioid Use Disorder, 2016-2020.
2016-2020 年阿片类药物使用障碍患者医学建议出院前的趋势。
- DOI:10.1001/jama.2023.21288
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Thakrar,AshishP;Lowenstein,Margaret;Greysen,SRyan;Delgado,MKit
- 通讯作者:Delgado,MKit
Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series.
- DOI:10.1002/emp2.12880
- 发表时间:2023-02
- 期刊:
- 影响因子:2.3
- 作者:Spadaro, Anthony;Faude, Sophia;Perrone, Jeanmarie;Thakrar, Ashish P. P.;Lowenstein, Margaret;Delgado, M. Kit;Kilaru, Austin S. S.
- 通讯作者:Kilaru, Austin S. S.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret Lowenstein其他文献
Margaret Lowenstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret Lowenstein', 18)}}的其他基金
Improving transitions of care for hospitalized patients with opioid use disorder
改善阿片类药物使用障碍住院患者的护理过渡
- 批准号:
10525374 - 财政年份:2022
- 资助金额:
$ 19.29万 - 项目类别:
相似海外基金
Integrating mental health screening into endocrinology ambulatory care
将心理健康筛查纳入内分泌门诊护理
- 批准号:
23K16283 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improving Diagnostic Equity in Ambulatory care Settings (I.D.E.A.S.): Research to Practice
提高门诊护理环境中的诊断公平性 (I.D.E.A.S.):研究到实践
- 批准号:
10830121 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Patient-Centered Stewardship to Improve Antibiotic Use in Ambulatory Care
以患者为中心的管理,以改善门诊护理中抗生素的使用
- 批准号:
10801756 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Resilience to Covid-19 Disrupted Chronic Condition Care for Older Veterans At Risk of Hospitalization: Role of VA Ambulatory Care and VA Extended Care Home and Community-Based Care Supports
有住院风险的老年退伍军人对 Covid-19 中断的慢性病护理的恢复能力:VA 门诊护理和 VA 延伸护理之家和社区护理支持的作用
- 批准号:
10632920 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Patient-Reported Diagnostic Safety Events in Ambulatory Care Settings: A National Survey of Systemic Influences, Disparities and Persisting Consequences
门诊医疗机构中患者报告的诊断安全事件:系统性影响、差异和持续后果的全国调查
- 批准号:
10830011 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Evaluating the Impact of Telemedicine on Ambulatory Care
评估远程医疗对门诊护理的影响
- 批准号:
10438959 - 财政年份:2022
- 资助金额:
$ 19.29万 - 项目类别:
Evaluating the Impact of Telemedicine on Ambulatory Care
评估远程医疗对门诊护理的影响
- 批准号:
10606533 - 财政年份:2022
- 资助金额:
$ 19.29万 - 项目类别:
Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
组件 A _ 德克萨斯州季节性流感、COVID-19 和其他呼吸道病毒疫苗针对急性疾病门诊护理的可信有效性措施(以及组件 D)。
- 批准号:
10618502 - 财政年份:2022
- 资助金额:
$ 19.29万 - 项目类别:
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
RFA-IP-22-004,组件 A _ 德克萨斯州季节性流感、COVID-19 和其他呼吸道病毒疫苗针对急性疾病门诊护理的可信有效性措施(和组件 D)。
- 批准号:
10698200 - 财政年份:2022
- 资助金额:
$ 19.29万 - 项目类别:
Acute Care Use by Patients with Inflammatory Arthritis Conditions: Health System Impact and Solutions for Ensuring Appropriate Ambulatory Care Access
炎症性关节炎患者的急性护理使用:卫生系统影响和确保获得适当门诊护理的解决方案
- 批准号:
456742 - 财政年份:2021
- 资助金额:
$ 19.29万 - 项目类别:
Operating Grants